Gregory B. Lesinski, PhD, MPH

Dr. Lesinski's research is focused on gaining a greater understanding of the interactions between the host immune system and tumor cells.

Titles and Roles

John Kauffman Family Professorship for Pancreatic Cancer Research: Emory University School of Medicine
Professor, Department of Hematology and Medical Oncology: Emory University School of Medicine
Associate Director for Basic Research and Shared Resources: Winship Cancer Institute of Emory University
Co-Director Translational GI Malignancy Program: Winship Cancer Institute of Emory University
Vice Chair for Basic Research, Department of Hematology and Medical Oncology: Emory University School of Medicine

Research Program: Cancer Immunology

Biography

Gregory B. Lesinski, PhD, MPH, is professor and serves as vice chair for basic research in the Department of Hematology and Medical Oncology at Emory University School of Medicine. Dr. Lesinski also serves as Winship Cancer Institute's associate director for basic research and shared resources where he provides oversight and direction for the development and growth of Winship's basic scientific activities across the cancer center’s four research programs. Prior to joining Emory, Dr. Lesinski was associate professor in the Department of Internal Medicine, Division of Medical Oncology at The Ohio State University.

Dr. Lesinski holds professional memberships with American Association for Cancer Research, Society for Melanoma Research, Society for Immunotherapy of Cancer and American Association of Immunologists.

Education

Dr. Lesinski received his PhD in Biomedical Sciences from The Medical College of Ohio in Toledo, Ohio. He obtained his MPH in Clinical Investigation from The Ohio State University in Columbus, Ohio. He completed his post-doctoral training at The Ohio State University.

Research

Dr. Lesinski's research is focused on gaining a greater understanding of the interactions between the host immune system and tumor cells. The ultimate goal is to use this knowledge to develop novel therapeutic or chemo-preventative approaches to help patients with cancer, and improve upon existing therapies. Of particular interest are modulation of cytokines and downstream signaling pathways to maximize the effect of immune based therapy.

Publications

Dr. Lesinski has published numerous articles in peer-reviewed journals including Journal of Immunology, Journal of the National Cancer Institute, and Journal of Clinical Investigation.

Publications Publication Date